Skip to main
JANX

Janux Therapeutics (JANX) Market Capitalization Overview

Market Cap: $821.02M as of Jan 2, 2026

$821.02M
$208.12M (20.22%)past month
As of Jan 2, 2026, Janux Therapeutics (JANX) has a market capitalization of $821.02M. Over the past 30 days, its market cap has decreased by -59.84%, while in the last 12 months, it has decreased by -1.09%.

Market capitalization represents the total value of Janux Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Janux Therapeutics (JANX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Janux Therapeutics (JANX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Janux Therapeutics (JANX) Market Cap History

DateMarket CapChange
Dec 1, 2025$2.05B+24.30%
Nov 3, 2025$1.65B+15.49%
Oct 1, 2025$1.43B+3.67%
Sep 2, 2025$1.38B-1.46%
Aug 1, 2025$1.40B+1.46%
Jul 1, 2025$1.38B-7.16%
Jun 2, 2025$1.48B-21.87%
May 1, 2025$1.90B+19.54%
Apr 1, 2025$1.59B-13.87%
Mar 3, 2025$1.84B-24.34%
Feb 3, 2025$2.44B-20.98%
Jan 2, 2025$3.08B+45.93%

Janux Therapeutics (JANX) End of Year Market Cap History

DateMarket CapChange
2026$821.02M-1.09%
2025$830.04M-73.18%
2024$3.10B+524.68%
2023$495.39M-9.72%
2022$548.71M-33.17%
2021$820.99M

FAQs About Janux Therapeutics (JANX) Market Cap

As of Jan 2, 2026, the market capitalization of Janux Therapeutics (JANX) is $821.02M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Janux Therapeutics’s market capitalization has decreased by -20.22%, changing from $1.03B to $821.02M as of Jan 2, 2026.

In the last 3 months, Janux Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Janux Therapeutics’s market capitalization decreased from $3.10B in January to $830.04M in December, reflecting a -73.18% change.

In the past five years, Janux Therapeutics (JANX) has had a compound annual growth rate (CAGR) of 0.22% in market capitalization. This means its market cap has grown at an average rate of 0.22% per year.

Janux Therapeutics (JANX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.